Email a friend

PowderJect Pharmaceuticals completes vendor placing of shares and acquisition of SBL Vaccin from Active Biotech for £35.5m, 75 per cent of which came from the placing.

Please complete the form below.

Required fields Mandatory fields

Mandatory
Mandatory
Mandatory
(Separate multiple email addresses with commas)
Mandatory fields